Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jana Samarin, Hana Nuskova, Piotr Fabrowski, Mona Malz, Eberhard Amtmann, Minerva J. Taeubert, Daniel Pastor-Flores, Daniel Kazdal, Roman Kurilov, Nicole de Vries, Hannelore Pink, Franziska Deis, Johanna Hummel-Eisenbeiss, Kamini Kaushal, Tobias P. Dick, Gerhard Hamilton, Martina Muckenthaler, Moritz Mall, Bryce Lim, Taishi Kanamaru, Glynis Klinke, Martin Sos, Julia Frede, Aubry K. Miller, Hamed A

Journal title: bioRxiv

Journal publisher: Cold Spring Harbor Laboratory

Published year: 2024

DOI identifier: 10.1101/2024.11.06.621846